Zinc-based organometallic nanoparticles, their manufacturing method, and photoresist
Zinc-based organometallic nanoparticles with a core-shell structure address the complexity of conventional photoresists by enabling precise patterning across various light sources, enhancing sensitivity and resolution in semiconductor manufacturing.
Patent Information
- Application Number
- JP2023538908
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-12-21
- Filing Date
- 2021-12-23
- Publication Date
- 2024-11-06
- Estimated Expiration
- 2041-12-23
Smart Images

Figure 0007578231000004 
Figure 0007578231000005 
Figure 0007578231000006
Abstract
Description
[Technical field]
[0001] <CROSS REFERENCE TO RELATED APPLICATIONS> This application claims priority to a Chinese patent application filed on December 24, 2020, bearing application number 202011547342.7 and entitled "Photoresist, manufacturing method, patterning method, and manufacturing method for printed circuit board," and to a Chinese patent application filed on December 21, 2021, bearing application number 202111573387.6 and entitled "Zinc-based organometallic nanoparticles and manufacturing method thereof, and photoresist," the entire contents of which are hereby incorporated by reference into this application.
[0002] The present application relates to the technical field of photoresists, and in particular to zinc-based organometallic nanoparticles and a method for producing the same, and photoresists. [Background technology]
[0003] Photoresist refers to a corrosion-resistant material whose solubility changes when irradiated with ultraviolet light, electron beams, particle beams, extreme ultraviolet (EUV), or X-rays. Photoresists are widely used in the patterning transfer in the manufacturing process of semiconductor integrated circuits, liquid crystal panels, and high-end optical devices. According to Moore's Law, the semiconductor integration density per unit area doubles every 18 to 24 months. With the continuous advancement of semiconductor technology, the size of semiconductors is constantly shrinking, and higher requirements are put forward for the reduction of feature size in semiconductor processes. In order to meet the more advanced semiconductor manufacturing process and achieve finer feature sizes, photolithography technology is also constantly developing, from photolithography technologies such as I-line, G-line, deep ultraviolet (DUV, deep ultra-violet), 193 nm, and immersion 193 nm, to microfabrication methods such as extreme ultraviolet photolithography and electron beam photolithography.
[0004] Conventional photoresists have complex components, including photoresist resin body, sensitizer, leveling agent, stabilizer, dispersant, thickener and solvent, and the manufacturing process is complicated, and the requirements for the control process of the compounding ratio and purity are very high. Conventional photoresists contain high molecular weight polymers and various additives, so their components are complex, the size distribution of photoresist components is wider, there are components of various sizes, and the size structure of some components can reach 10-20 nm, which makes it difficult to control the size of photoresist patterning and may cause many defects. In addition, the use of conventional photoresists is limited by the wavelength of the light source, and different photoresists are required to match light sources with different wavelengths. Summary of the Invention [Problem to be solved by the invention]
[0005] Based on this, there is a need to provide zinc-based organometallic nanoparticles and methods for producing the same, as well as photoresists. [Means for solving the problem]
[0006] Zinc-based organometallic nanoparticles having a core-shell structure and the general formula: Zn x O y [A] 2x [B]2 (where x is 2 or 3, 2x≦y≦4x, and Zn x O y is the core of the core-shell structure, A is a first organic ligand, and B is a second organic ligand, the first organic ligand A and the second organic ligand B jointly constitute the shell of the core-shell structure, the first organic ligand A is one or more selected from a substituted or unsubstituted aliphatic group and a substituted or unsubstituted aromatic group, and the second organic ligand B is one or more selected from organic amines and derivatives thereof.
[0007] In some embodiments, the zinc based organometallic nanoparticles comprise photoreactive groups.
[0008] In some embodiments, at least one of the first organic ligand A and the second organic ligand B comprises a photoreactive group.
[0009] In some embodiments, the photoreactive group is one or more selected from a carbon-carbon double bond, an acyloxy group, an acyl group, an aldehyde group, a carboxyl group, an ester group, and an amino group.
[0010] In some embodiments, x=3 and two Zn atoms are x O y They are located at opposite ends of the core and bond to the N atoms in the two second organic ligands B, respectively.
[0011] In some embodiments, x=2, two Zn atoms are bonded together to the first organic ligand A via surrounding O atoms, and two N atoms in the second organic ligand B are bonded together to the Zn x O y They are located at both ends of the core and bond to the two Zn atoms, respectively.
[0012] In some embodiments, the zinc based organometallic nanoparticles have the general formula Zn2O8[A]4[B]2, Zn3O 12 [A]6[B]2 or Zn3O 10 [A]6[B]2.
[0013] In some embodiments, the zinc based organometallic nanoparticles have a size between 1 nm and 3 nm.
[0014] In some embodiments, the aliphatic group is a C1-C10 open chain hydrocarbon group or a C3-C10 cyclic hydrocarbon group, and the aromatic group has one or more aromatic rings, substituted aromatic rings, heteroaromatic rings, or substituted heteroaromatic rings, and is preferably a phenyl group or a substituted phenyl group.
[0015] In some embodiments, the first organic ligand A is represented by one or more of the following structures, where the dotted line represents the Zn x O y The bond that connects to the core O is shown. JPEG0007578231000001.jpg15170
[0016] (wherein R1 is independently one or more selected from H, halogen, carboxyl, carbonyl, hydroxyl, amino, R, OR, NR2, SR, C(O)R, C(O)OR, C(O)NR2, CN, CF3, NO2, SO2, SOR, and SOR. R is a substituent, and in some embodiments, R is independently a C1-C10 alkyl group, a C2-C10 alkenyl group, a C2-C10 alkynyl group, a C3-C10 aryl group, a C3-C10 aralkyl group, or a C3-C10 naphthenic group, and in some embodiments, R is independently a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a phenyl group, or an alkylphenyl group.)
[0017] In some embodiments, the second organic ligand B is any one or more selected from linear amines and derivatives thereof, cyclic amines and derivatives thereof, the cyclic amines and derivatives thereof are any one or more selected from imidazole and derivatives thereof, pyridine and derivatives thereof, pyrrole and derivatives thereof, pyrimidine and derivatives thereof, pyridazine and derivatives thereof, and piperidine and derivatives thereof, and the linear amines and derivatives thereof are any one or more selected from trimethylamine, triethylamine, tripropylamine, triisopropylamine, triethanolamine, dimethylamine, diethylamine, dipropylamine, diisopropylamine, and ethyldiisopropylamine, but are not limited thereto.
[0018] In some embodiments, the zinc based organometallic nanoparticles have the general formula Zn x O y [A1,A2] 2x [B1]2, Zn x O y [A1] 2x [B1,B2]2 or Zn x O y [A1,A2] 2x[B1, B2]2, where A1 and A2 each represent two different first organic ligands A, and B1 and B2 each represent two different second organic ligands B.
[0019] A method for preparing zinc-based organometallic nanoparticles includes the following steps:
[0020] mixing a zinc metal salt with an organic solvent to obtain a zinc metal salt solution;
[0021] The zinc metal salt solution is mixed with a first organic ligand source and a second organic ligand source, and reacted with each other under heating and stirring;
[0022] The reaction product is subjected to vacuum rotary evaporation to remove the organic solvent.
[0023] In some embodiments, the molar ratio of the zinc metal salt, the first organic ligand source, and the second organic ligand source is 1:(0.5-6):(0.5-6).
[0024] The zinc-based organometallic nanoparticle crystals are obtained by redissolving the zinc-based organometallic nanoparticles or the product of the vacuum rotary evaporation in the organic solvent and crystallizing the redissolved zinc-based organometallic nanoparticles or the product of the vacuum rotary evaporation in the organic solvent.
[0025] The photoresist is obtained by dispersing either one or both of the zinc-based organometallic nanoparticles and the zinc-based organometallic nanoparticle crystals in an organic dispersion solvent.
[0026] In some embodiments, the photoresist comprises the zinc based organometallic nanoparticles and an organic dispersing solvent. Effect of the Invention
[0027] The present application relates to novel Zn, also called photoresist particles. x O yProvided is a self-initiated zinc-based organometallic nanoparticle based on a core and an organic ligand. The photoresist particles can be aggregated under light irradiation without the need for photoacid generators, photoacid catalysts, photoinitiators, etc., and the solubility in the developer is reduced, but the photoresist particles in the unexposed area do not aggregate and dissolve in the developer, so that the unexposed area can be removed after development. When only photoresist particles are included, patterning can be produced under various exposure conditions such as ultraviolet light, deep ultraviolet light, electron beam, and extreme ultraviolet light, and extremely high sensitivity and resolution can be obtained. [Brief description of the drawings]
[0028] In order to more clearly describe the technical solutions of the embodiments of the present disclosure, the following briefly describes the drawings necessary for describing the embodiments. Obviously, the drawings described below are only some embodiments of the present disclosure, and those skilled in the art can further obtain other drawings based on these drawings without creative efforts. [Figure 1] FIG. 1 is a schematic diagram showing the structure of a photoresist particle according to one embodiment of the present application. [Diagram 2] FIG. 2 is a particle size distribution diagram of the photoresist particles according to the embodiment of the present application and the conventional photoresist particles. [Diagram 3] FIG. 3 is a diagram of the single crystal structure of a photoresist particle according to Example 1 of the present application. [Figure 4] FIG. 4 is a chemical structure diagram of the photoresist particles according to Example 1 of the present application. [Diagram 5] FIG. 5 is a diagram of the single crystal structure of a photoresist particle according to Example 2 of the present application. [Figure 6] FIG. 6 is a chemical structure diagram of a photoresist particle according to Example 2 of the present application. [Figure 7] FIG. 7 is a diagram of the single crystal structure of a photoresist particle according to Example 3 of the present application. [Figure 8] FIG. 8 is a chemical structure diagram of a photoresist particle according to Example 3 of the present application. [Figure 9]FIG. 9 is a diagram of the single crystal structure of a photoresist particle according to Example 4 of the present application. [Figure 10] FIG. 10 is a chemical structure diagram of a photoresist particle according to Example 4 of the present application. [Figure 11] FIG. 11 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposing the photoresist particles according to Example 5 of the present application to deep ultraviolet light at a dose of 45 mJ / cm 2 . [Figure 12] FIG. 12 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposure to deep ultraviolet light at a dose of 75 mJ / cm2 according to Example 5 of the present application. [Figure 13] FIG. 13 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposure to deep ultraviolet light at a dose of 110 mJ / cm2 according to Example 5 of the present application. [Figure 14] FIG. 14 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposing the mask according to Example 5 of the present application to an electron beam at a dose of 50 μC. [Figure 15] FIG. 15 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposing another mask to an electron beam at a dose of 50 μC according to Example 5 of the present application. [Figure 16] FIG. 16 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposure to an electron beam at a dose of 50 μC in another mask according to Example 5 of the present application. [Figure 17] FIG. 17 is a scanning electron microscope photograph of a patterned photoresist layer obtained by exposure to extreme ultraviolet light at a dose of 7 mJ / cm2 according to Example 5 of the present application. [Figure 18] FIG. 18 is an optical photograph of a patterned photoresist layer obtained by exposure to 254 nm wavelength ultraviolet light at a dose of 300 mJ / cm2 under air test conditions according to Example 5 of the present application. [Figure 19] FIG. 19 is an optical microscope photograph of a patterned photoresist layer obtained after exposure to 254 nm wavelength UV light at a dose of 300 mJ / cm2 under air test conditions according to Example 5 of the present application. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0029] To facilitate understanding of the present application, the present application will now be described more comprehensively with reference to the accompanying drawings, in which preferred embodiments of the present application are shown. However, the present application may be embodied in many different forms and is not limited to the embodiments set forth herein. On the contrary, the purpose of providing these embodiments is to provide a more complete and comprehensive understanding of the disclosure of the present application.
[0030] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art. The terms used in the present specification are merely for describing specific examples and are not intended to limit the present specification.
[0031] The scope of "light" as used herein includes, but is not limited to, ultraviolet, deep ultraviolet, and extreme ultraviolet light, and more broadly includes electron beam, x-ray, and the like.
[0032] The present embodiment provides photoresist particles, the crystal structure of the photoresist particles is a core-shell structure, and the general formula of the photoresist particles is Zn x O y [A] 2x [B]2 (where x is 2 or 3, 2x≦y≦4x, and Zn x O yis the core of the core-shell structure, A is a first organic ligand, and B is a second organic ligand), and the first organic ligand A and the second organic ligand B together constitute the shell of the core-shell structure. The first organic ligand A is one or more selected from a substituted or unsubstituted aliphatic group and a substituted or unsubstituted aromatic group, and the second organic ligand B is one or more selected from organic amines and their derivatives. The photoresist particles may have a photoreactive group. Specifically, at least one of the first organic ligand A and the second organic ligand B may have a photoreactive group, which reacts with the photoreactive groups of different photoresist particles under irradiation with light to aggregate the photoresist particles together, and further reduces the solubility of the exposed area in the developer.
[0033] The crystalline state of the photoresist particles refers to the state of the photoresist particles after they are dissolved in a solvent and then crystallized and precipitated.
[0034] The present application relates to a novel Zn x O y Self-initiated metal oxide nanoparticles based on a core and organic ligands (also referred to as photoresist particles or zinc-based organometallic nanoparticles in this application) are designed and manufactured. The photoresist particles aggregate in a developer under the action of light irradiation, thereby reducing the solubility, but the photoresist particles in the unexposed area do not aggregate and dissolve in the developer, so that the photoresist in the unexposed area can be removed after development. In particular, when only photoresist particles are contained, patterning can be produced under various exposure wavelength conditions such as ultraviolet light, deep ultraviolet light, electron beam, and extreme ultraviolet light, and extremely high sensitivity and resolution can be obtained. The core Zn of the photoresist particles x O y The number of Zn atoms in the shell is 2 to 3, and the shell is composed of two types of organic ligands. x O yThe core has a higher electron donating capacity and is more sensitive to different wavelengths of radiation or particle radiation, which can cause irradiated photoresist particles to aggregate together, thereby reducing the solubility of the exposed areas in the developer. Zn x O y Through the cooperation between the core and the first organic ligand A and / or the second organic ligand B having a photoreactive group, the photoresist particles themselves can be photosensitive, and can be directly used as a photoresist for patterning. The photoresist containing the photoresist particles can achieve the photosensitive effect without adding a photoacid generator, photoacid catalyst, photoinitiator, etc.
[0035] When the core of the photoresist particle is approximately considered as a sphere having an equator and two poles, in some embodiments, the content of the first organic ligand A decreases from the equator of the core toward the two poles, and the content of the second organic ligand B decreases from the two poles toward the equator. Optionally, the second organic ligand B is distributed within a range extending from the two poles to the equator by 10 to 45 degrees, and the first organic ligand A is distributed within a range extending from the equator to the two poles by 45 to 80 degrees. Both angles here refer to central angles on any cross section passing through the center of the sphere. Optionally, as shown in FIG. 1, only the second organic ligand B is included at the two poles, and only the first organic ligand A is included at the equator.
[0036] Because the volume of the core is small, the organic ligands basically tightly wrap around the outside of the core, the first organic ligand A and the second organic ligand B completely wrap around the core, and there is basically no blank space in the shell.
[0037] As shown in Figure 2, the size of the photoresist particles is 1nm-3nm. As can be seen from the characterization of the single crystal structure data, the photoresist particles corresponding to the general formula formed by the cooperation of the first organic ligand A and the second organic ligand B have a precise structure, and as can be seen from the size of the material, compared with the conventional photoresist, the photoresist of the present application can obviously reduce the edge roughness of the patterning after exposure.
[0038] In photoresist particles, Zn x O y Each Zn atom in the core may be bonded to surrounding O atoms and / or N atoms in the second organic ligand B. In some embodiments, the total number n of O and N atoms bonded to the same Zn atom may be 4, 5, or 6, thereby forming a tetrahedral (n=4), hexahedral (n=5), or octahedral (n=6) unit. The Zn atom is located at the center of the tetrahedron, hexahedron, or octahedron, and the O or N atom is located at the apex of the tetrahedron, hexahedron, or octahedron. Adjacent Zn atoms may be bonded directly through O atoms, i.e., forming a Zn-O-Zn bond, in which the polyhedra may share one oxygen atom. Alternatively, adjacent Zn atoms may be bonded jointly through O atoms to the same first organic ligand A to form a Zn-OCO-Zn group.
[0039] In some embodiments, x=3, and three Zn atoms are arranged sequentially to form an acyclic structure. The two Zn atoms at both ends are directly bonded to N atoms in two second organic ligands B, respectively, and the Zn atom at the center is directly bonded only to an O atom. Since the N atoms are derived from the second organic ligand B, the second organic ligand B is also located at the two poles of the core.
[0040] In some embodiments, x=2, and the two Zn atoms are not directly bonded to each other through an O atom, but are bonded to the first organic ligand A through the surrounding O atoms and through the Zn-OCO-Zn group. x O y They are located at both ends of the core and bond to two Zn atoms, respectively. Since N comes from the second organic ligand B, the second organic ligand B is also located at the two poles of the core.
[0041] More specifically, in some embodiments, the photoresist particles have the general formula Zn x O 4x [A] 2x [B]2, e.g., Zn2O8[A]4[B]2, Zn3O 12[A]6[B]2, and in some other embodiments, the general formula of the photoresist particles is ZnO 10 It may be [A]6[B]2.
[0042] The first organic ligand A is connected to Zn via its C atom. x O y The second organic ligand B is bonded directly to the O atom in the core via its N atom to Zn x O y In some embodiments, the same first organic ligand A is bonded to two O atoms and further bonded to two Zn atoms through the two O atoms. In the synthesis of photoresist particles, Zn x O y The O atoms in the core are at least partially from the reactant for forming the first organic ligand A (also referred to herein as the first organic ligand source), e.g., from an oxygen-containing unsaturated bond, e.g., a carboxyl group or a carbonyl group, contained in the first organic ligand source, and position the first organic ligand A between the two poles of the core, e.g., at the equator.
[0043] The first organic ligand A is selected from a substituted or unsubstituted aliphatic group or a substituted or unsubstituted aromatic group. The aliphatic group may be a C1-C10 chain hydrocarbon group or a C3-C10 cyclic hydrocarbon group. The chain hydrocarbon group may be a straight or branched alkyl group, an alkenyl group, or an alkynyl group. In the substituted aliphatic group, the hydrogen of the chain hydrocarbon group or the cyclic hydrocarbon group may be substituted with one or more substituents. The aromatic group may have one or more aromatic rings, substituted aromatic rings, heteroaromatic rings, or substituted heteroaromatic rings, and in some embodiments may be a phenyl group or a substituted phenyl group. In the substituted aromatic group, the hydrogen on the aromatic ring, for example the benzene ring, may be substituted with one or more substituents. The substituent may be one or more selected from halogen, carboxyl, carbonyl, hydroxyl, amino, R, OR, NR2, SR, C(O)R, C(O)OR, C(O)NR2, CN, CF3, NO2, SO2, SOR, and SOR. R may be independently a C1-C10 alkyl group, a C2-C10 alkenyl group, a C2-C10 alkynyl group, a C3-C10 aryl group, a C3-C10 aralkyl group, or a C3-C10 naphthenic group, but is not limited thereto. In some embodiments, R may be independently a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a phenyl group, or an alkylphenyl group, specifically, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a vinyl group, an allyl group, an ethynyl group, or the like. The alkylphenyl group may be, for example, a methylphenyl group, an ethylphenyl group, an n-propylphenyl group, an isopropylphenyl group, etc. In some embodiments, the total number of carbon atoms in each first organic ligand A may be 1 to 10. In some embodiments, the first organic ligand A is any one or more of benzene and its derivatives, alkanes, olefinic hydrocarbons, and carboxylic acids. The derivative may refer to a group in which a hydrogen atom in benzene is replaced with the above-mentioned substituent.
[0044] In some embodiments, the first organic ligand A is represented by one or more of the following structures, where the dotted line represents the Zn x O y The bond that connects to the core O is shown. JPEG0007578231000002.jpg15170
[0045] In the above, R1 is independently one or more selected from H, halogen, carboxyl group, carbonyl group, hydroxyl group, amino group, R, OR, NR2, SR, C(O)R, C(O)OR, C(O)NR2, CN, CF3, NO2, SO2, SOR, and SOR, and the number of R1 is 1 to 5, and each R1 is bonded to C in the benzene ring. In some embodiments, R1 is independently a C1-C4 alkyl group, a C2-C4 alkenyl group, or a C2-C4 alkynyl group.
[0046] In some embodiments, the first organic ligand A is one or more selected from the following structures: JPEG0007578231000003.jpg88170
[0047] In some embodiments, the second organic ligand B is selected from organic amines and derivatives thereof, including, but not limited to, any one or more of linear amines and derivatives thereof, cyclic amines and derivatives thereof. Derivatives may refer to substituted linear amines or cyclic amines formed by substituting hydrogen atoms in an organic amine with one or more substituents. The substituents may be, but are not limited to, one or more selected from halogen, carboxyl group, carbonyl group, hydroxyl group, amino group, R, OR, NR2, SR, C(O)R, C(O)OR, C(O)NR2, CN, CF3, NO2, SO2, SOR, and SOR. R may be, but is not limited to, independently H, C1-C10 alkyl group, C2-C10 alkenyl group, C2-C10 alkynyl group, C3-C10 aryl group, C3-C10 aralkyl group, or C3-C10 naphthenic group. In some embodiments, R is independently a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, a phenyl group, or an alkylphenyl group, such as, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a vinyl group, an allyl group, an ethynyl group, etc. The alkylphenyl group may be, for example, a methylphenyl group, an ethylphenyl group, an n-propylphenyl group, an isopropylphenyl group, etc.
[0048] In some embodiments, the cyclic amine and its derivatives may be any one or more selected from imidazole and its derivatives, pyridine and its derivatives, pyrrole and its derivatives, pyrimidine and its derivatives, pyridazine and its derivatives, and piperidine and its derivatives, but are not limited thereto. The linear amine and its derivatives may be any one or more selected from trimethylamine, triethylamine, tripropylamine, triisopropylamine, triethanolamine, dimethylamine, diethylamine, dipropylamine, diisopropylamine, and ethyldiisopropylamine, but are not limited thereto. The imidazole and its derivatives may be any one or more selected from methylimidazole and vinylimidazole, but are not limited thereto. The pyridine and its derivatives may be any one or more selected from methylpyridine, vinylpyridine, methylpyrrolidine, and perhydropyrimidine, but are not limited thereto. The pyrrole and its derivatives may be any one or more selected from methylpyrrole and vinylpyrrole, but are not limited thereto. Pyridazine and its derivatives may be, but are not limited to, any one or more of vinylpyridazine, divinylpyridazine, etc. Piperidine and its derivatives may be, but are not limited to, vinylpiperidine, etc. In some embodiments, the second organic ligand B is an N-containing unsaturated structure, which can increase the electron-donating ability, and further makes the photoreactive group more likely to accept electrons, have higher reaction activity, and further promote the occurrence of reaction between the photoreactive groups.
[0049] In some embodiments, at least one of the first organic ligand A and the second organic ligand B may have a photoreactive group. The photoreactive groups of different photoresist particles may react with each other under irradiation with light, for example to generate a linking group, and the photoresist particles are linked to each other via the linking group. Zinc oxide Zn x O yThe core has a higher electron-donating ability, which makes the photoreactive group more likely to receive electrons and has a higher reaction activity, allowing the photoresist particles to perform photosensitization themselves, and does not require the addition of a photoacid generator, a photoacid catalyst, a photoinitiator, etc. The reaction between the photoreactive groups may be, for example, but not limited to, one or more of an addition reaction and a condensation reaction. The addition reaction may be, for example, one or more of a radical addition reaction, a nucleophilic addition reaction, and an electrophilic addition reaction. The photoreactive group may be, for example, one or more of a carbon-carbon double bond, a carbonyl group (e.g., an acyloxy group, an acyl group, an aldehyde group, an ester group, etc.), a carboxyl group, and an amino group.
[0050] In one embodiment, at least one of the first organic ligand A and the second organic ligand B has a carbon-carbon double bond. Under light irradiation, a radical addition reaction may occur between the carbon-carbon double bonds of different photoresist particles to generate a linking group -CC-.
[0051] In another embodiment, the first organic ligand A and the second organic ligand B both have a photoreactive group, the photoreactive group of the first organic ligand A is an aldehyde group (-CHO), and the second organic ligand B is an amino group (e.g., -NH-, -NH2-), and the above two types of photoreactive groups of different photoresist particles can react with each other under irradiation with light to generate a linking group -CN-.
[0052] In some embodiments, the first organic ligand A has an aromatic ring structure, and the second organic ligand B is selected from cyclic amines and their derivatives, particularly from imidazole and its derivatives. The aromatic ring structure (e.g., phenyl group) of the first organic ligand A and the cyclic amine structure (e.g., imidazole group) of the second organic ligand B have higher electron-donating ability, making the photoreactive group more likely to accept electrons, and further facilitating the reaction between the photoreactive groups.
[0053] In the photoresist particles, the first organic ligand A and the second organic ligand B may each be one or more organic ligands. For example, when they are selected from one or two organic ligands, the general formula of the photoresist particles is Zn x O y [A1,A2] 2x [B1]2, Zn x O y [A1] 2x [B1,B2]2, Zn x O y [A1,A2] 2x [B1, B2]2. A1 and A2 each represent two different first organic ligands A, e.g., two different substituted or unsubstituted aliphatic or aromatic groups. B1 and B2 each represent two different second organic ligands B, e.g., two different organic amines.
[0054] The present embodiment further provides a method for preparing photoresist particles, comprising the steps of: mixing a zinc metal salt with an organic solvent to obtain a zinc metal salt solution; mixing the zinc metal salt solution with a first organic ligand source and a second organic ligand source, and reacting the mixture with heating and stirring; and subjecting the reaction product to vacuum rotary evaporation to remove the organic solvent; The molar ratio of the metal salt of zinc, the first organic ligand source, and the second organic ligand source is 1:(0.5 to 6):(0.5 to 6).
[0055] The first organic ligand source is a reactant for forming the first organic ligand A, and includes a group as the first organic ligand A, i.e., the substituted or unsubstituted aliphatic group or the substituted or unsubstituted aromatic group. It further includes an oxygen-containing unsaturated bond, such as a carboxyl group or a carbonyl group, that can react with a zinc metal salt. The second organic ligand is bonded to the Zn atom of the core by participating in the reaction through its nitrogen atom, and therefore the second organic ligand may directly function as a second organic ligand source.
[0056] In the preparation method of the present application, the molar ratio of the zinc metal salt, the first organic ligand source, and the second organic ligand source plays an important role in obtaining photoresist particles having the above-mentioned specific structure of the present application, and the molar ratio of the zinc metal salt, the first organic ligand source, and the second organic ligand source is 1:(0.5-6):(0.5-6). After the reaction and before removing the organic solvent, the solution obtained is clear and transparent, and the photoresist particles produced are not precipitated in the form of precipitation but are uniformly dispersed in the organic solvent. If the amount of the first organic ligand source or the second organic ligand source added is too large or too small, a white precipitate that cannot be dissolved in the organic solvent is formed, or photoresist particles having a specific structure cannot be obtained.
[0057] In some embodiments, the heating and stirring is performed at a temperature of 50-120° C. for a period of 10-40 hours, and optionally at a temperature of 50-80° C. for a period of 15-28 hours. If the temperature is too low, the reaction rate is too slow, and if the temperature is too high, the reaction is unstable, and a white precipitate that cannot be dissolved in an organic solvent is formed instead of photoresist particles with a specific structure.
[0058] In some embodiments, the temperature of the vacuum rotary evaporation is 20-80°C. For example, it may be selected from 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C, 80°C, etc. Optionally, the temperature of the vacuum rotary evaporation is 20-40°C. If the temperature is too low, the reaction rate is too slow, and if the temperature is too high, the properties of the photoresist particles in vacuum are not stable, and the groups are easily destroyed. The temperature of the vacuum rotary evaporation is generally lower than the temperature of the heating and stirring.
[0059] In some embodiments, the pressure of the vacuum rotary evaporation is between 5 and 40 mbar, such as 5 mbar, 10 mbar, 15 mbar, 20 mbar, 25 mbar, 30 mbar, 35 mbar, 40 mbar, etc.
[0060] The purpose of the vacuum rotary evaporation is to remove the organic solvent more quickly and make it more difficult for the zinc-based organometallic nanoparticles to grow as crystal nuclei, thereby forming single-crystalline, i.e., monodisperse, zinc-based organometallic nanoparticles.
[0061] The organic solvent is not particularly limited, and may be, for example, any one or more selected from ethyl acetate, butyl acetate, propylene glycol monoethyl ether acetate, propylene glycol methyl ether acetate, 1-ethoxy-2-propanol, methyl alcohol, ethyl alcohol, and propyl alcohol, but is not limited thereto.
[0062] The embodiment of the present application further provides photoresist particle crystals, which are obtained by redissolving the photoresist particles of any one of the above embodiments in an organic solvent and then crystallizing them. During the crystallization process, the solvent may be gradually removed to grow the crystal nuclei of zinc-based organometallic nanoparticles. In one embodiment, the photoresist particles obtained by the vacuum rotary evaporation may be redissolved in an organic solvent, and then left to completely volatilize the organic solvent to obtain the photoresist particle crystals. In another embodiment, the reaction product before the vacuum rotary evaporation may be directly left to completely volatilize the organic solvent to obtain the photoresist particle crystals. The photoresist particle crystals can be observed using a double microfocus single crystal X-ray diffractometer and analyzed using single crystal analysis software Olex2 to obtain the single crystal structure and size characteristics of the photoresist particles.
[0063] The present embodiment further provides a photoresist, which is obtained by dispersing any one or two of the photoresist particles or photoresist particle crystals of any one of the above embodiments in an organic dispersing solvent, for example, by dissolving the photoresist particles in the organic solvent to form a clear and transparent solution.
[0064] In some examples, the organic dispersion solvent may be any one or more selected from ethyl acetate, butyl acetate, propylene glycol monoethyl ether acetate, propylene glycol methyl ether acetate, 1-ethoxy-2 propanol, methyl alcohol, ethyl alcohol, and propyl alcohol.
[0065] An embodiment of the present application further provides a method for patterning a photoresist, the method including the steps of: applying the photoresist to a surface of a substrate, and removing the organic dispersion solvent in the photoresist to form a pre-deposition layer on the surface of the substrate; performing an exposure operation by irradiating a light source onto the pre-deposition layer of the substrate through a mask to form photoresist particle aggregates in the exposed areas of the pre-deposition layer; Applying a developer onto the exposed pre-deposited layer, such that the unexposed areas on the pre-deposited layer blocked by the mask are dissolved in the developer, while the exposed areas of the pre-deposited layer remain on the substrate to form photoresist particle agglomerates, thereby forming a patterned photoresist layer.
[0066] The photoresist patterning process of the present application allows for the production of patterns without the addition of photoacid generators, catalysts, or photoinitiators.
[0067] The present application further provides a combination product of photoresist, comprising the photoresist of any one of the above embodiments and a developer, the combination product of photoresist being for forming a patterned photoresist layer.
[0068] In some embodiments, the light source used for exposure is any one selected from ultraviolet light, deep ultraviolet light, electron beam, and extreme ultraviolet light sources. The wavelength of the extreme ultraviolet light is 10 nm to 14 nm. The wavelength of the ultraviolet light may be, for example, 254 nm or 365 nm. The photoresist of the present application can be used with any one of the exposure light sources used in existing photolithography techniques, and none of them require a photoacid generator, a catalyst, or an initiator.
[0069] In some embodiments, the substrate is selected from silicon substrates or other substrates that are not soluble in the developer selected according to the actual needs.
[0070] In some embodiments, regarding the mask, when a deep ultraviolet and longer wavelength light source is used for exposure, the mask used is a transmission mask, and when an extreme ultraviolet light source is used for exposure, the mask used is a reflection mask, and when the light source for exposure is an electron beam light source, a mask may or may not be provided, and the electron beam performs exposure on the pre-deposition layer based on the patterning designed by software.
[0071] In some embodiments, the light source used in the exposure step is an ultraviolet, deep ultraviolet or extreme ultraviolet light source, and the exposure dose of the exposure step is between 4 and 1000 mJ / cm 2 In some other embodiments, the light source used in the exposure step is an electron beam source and the dose is 10 μC / cm 2 ~10mC / cm 2 The exposure dose should be controlled within a suitable range, if the exposure dose is too small, the energy is too low, which is unfavorable to the polymerization of the photoresist particles in the exposed area, and is unfavorable to the formation of the solubility difference between the exposed area and the non-exposed area, resulting in a low development effect. If the exposure dose is too high, the photoresist in the non-exposed area may react, which reduces the accuracy of patterning.
[0072] In some embodiments, the developer is mainly used to dissolve the unagglomerated photoresist particles. The photoresist particles in the exposed regions form aggregates and are not dissolved in the developer or the aggregates in the exposed regions have a low solubility in the developer, so that even if they are partially dissolved, the exposed regions are still covered with the aggregates. The developer may be the same as the organic solvent in the photoresist, or may be different from the organic solvent in the photoresist. Optionally, the solubility of the photoresist particles in the developer is lower than that in the photoresist organic solvent, to avoid the photoresist particles dissolving in the developer due to insufficient polymerization degree after exposure, dissolving or partially dissolving the exposed regions, which would reduce the accuracy of the exposure pattern. In some embodiments, the developer may be any one or more selected from decahydronaphthalene, tetrahydronaphthalene, indene, indane, quinoline, 1-methylnaphthalene, methylbenzene, orthoxylene, metaxylene, paraxylene, ethyl acetate, butyl acetate, ethyl alcohol, n-propyl alcohol, isopropyl alcohol, n-butyl alcohol, n-hexane, and cyclohexane. In some embodiments, the development temperature may be room temperature, for example, 20-30°C.
[0073] In one embodiment, the thickness of the pre-deposition layer after removing the organic dispersion solvent may be 10 to 500 nm. Specifically, the thickness of the pre-deposition layer may be 10 nm to 50 nm, 50 nm to 100 nm, 100 nm to 150 nm, 150 nm to 200 nm, 200 nm to 250 nm, 250 nm to 300 nm, 300 nm to 350 nm, 350 nm to 400 nm, 400 nm to 450 nm, or 450 nm to 500 nm.
[0074] An embodiment of the present application further provides a method for manufacturing a printed circuit board, the method including the steps of: manufacturing a pre-patterned plate having a patterned photoresist layer on a silicon plate substrate according to the photoresist patterning method; Dry or wet etching the pre-patterned plate.
[0075] Example 1 1) 4.88 g (20 mmol) of benzoic acid and 1.92 g (20.4 mmol) of N-vinylimidazole were mixed in a flask, and 15 mL of ethyl acetate was added and mixed for 2 minutes to dissolve.
[0076] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0077] 3) After the reaction was completed, the mixture was rotary evaporated at 30°C for 20 minutes with a rotary evaporator, and the pressure was controlled at 30 mbar to obtain photoresist particle aggregates. The product was redissolved in ethyl acetate and left to stand to completely evaporate the ethyl acetate to obtain crystals. The photoresist particle crystals were observed using a dual microfocus single crystal X-ray diffractometer, and the obtained crystals were analyzed using single crystal analysis software Olex2, and the single crystal structure diagram shown in Figure 3 was obtained. The chemical formula of the obtained photoresist particles is Zn3O 12 [C7H5]6[C5N2H6]2. As shown in Figure 4, the particle size is smaller than 2 nm.
[0078] Example 2 1) 4.88 g (20 mmol) of benzoic acid and 1.67 g (20.4 mmol) of N-methylimidazole were mixed in a flask, and 15 mL of ethyl acetate was added and mixed for 2 minutes to dissolve.
[0079] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0080] 3) After the reaction was completed, the mixture was rotary evaporated at 30°C for 20 minutes with a rotary evaporator, and the pressure was controlled at 30 mbar to obtain photoresist particle aggregates. The product was redissolved in ethyl acetate and left to stand to completely evaporate the ethyl acetate to obtain crystals. The photoresist particle crystals were observed using a dual microfocus single crystal X-ray diffractometer, and the obtained crystals were analyzed using single crystal analysis software Olex2, and the single crystal structure diagram shown in Figure 5 was obtained. The chemical formula of the obtained photoresist particles is Zn3O 12 [C7H5]6[C4N2H6]2. As shown in Figure 6, the particle size is smaller than 2 nm.
[0081] Example 3 1) 2.44 g (10 mmol) of benzoic acid and 1.67 g (20.4 mmol) of N-methylimidazole were mixed in a flask, and 15 mL of ethyl acetate was added and mixed for 2 minutes to dissolve.
[0082] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0083] 3) After the reaction was completed, the mixture was rotary evaporated at 30°C for 20 minutes with a rotary evaporator, and the pressure was controlled at 30 mbar to obtain photoresist particle aggregates. The product was redissolved in ethyl acetate and left to stand to completely evaporate the ethyl acetate to obtain crystals. The photoresist particle crystals were observed using a dual microfocus single crystal X-ray diffractometer, and the obtained crystals were analyzed using single crystal analysis software Olex2, and the single crystal structure diagram shown in Figure 7 was obtained. The chemical formula of the obtained photoresist particles is Zn3O 10 [C7H5]4[C2H3O]2[C4N2H6]2. As shown in Figure 8, the particle size is smaller than 2 nm.
[0084] Example 4 1) 5.44 g (20 mmol) of 3-methylbenzoic acid and 1.92 g (20.4 mmol) of N-vinylimidazole were mixed in a flask, and 15 mL of ethyl acetate was added and mixed for 2 minutes to dissolve.
[0085] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 2 hours.
[0086] 3) After the reaction was completed, the mixture was rotary evaporated at 30°C for 20 min with a rotary evaporator, and the pressure was controlled to 30 mbar to obtain photoresist particle aggregates. The product was redissolved in ethyl acetate and left to evaporate the ethyl acetate completely to obtain crystals. The photoresist particle crystals were observed using a double microfocus single crystal X-ray diffractometer, and the obtained crystals were analyzed by single crystal analysis software Olex2, and the single crystal structure diagram shown in Figure 9 was obtained. The chemical formula of the obtained photoresist particles is Zn2O8[C8H7]4[C4N2H6]2. As shown in Figure 10, the particle size is smaller than 2 nm.
[0087] Example 5 1) 2.72 g (20 mmol) of 3-methylbenzoic acid, 2.44 g (20 mmol) of benzoic acid, and 1.92 g (20.4 mmol) of N-vinylimidazole were mixed in a flask, and 15 mL of ethyl acetate was added and mixed for 2 minutes to dissolve.
[0088] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0089] 3) After the reaction was completed, the mixture was rotary evaporated at 30°C for 20 min with a rotary evaporator and the pressure was controlled at 30 mbar to obtain photoresist particle aggregates. The product was redissolved in ethyl acetate and left to stand to completely evaporate the ethyl acetate to obtain crystals. The photoresist particle crystals were observed using a double microfocus single crystal X-ray diffractometer and the obtained crystals were analyzed using single crystal analysis software Olex2, and it was found that the obtained product was a mixture of two types of photoresist particles. The single crystal structure diagrams of the two types of photoresist particles are shown in Figures 3 and 9, respectively.
[0090] Fabrication of patterned photoresist layer 1 g of the photoresist particles of Example 5 was dissolved in 19 g of propylene glycol monomethyl ether acetate, uniformly dispersed, and then coated on a 2-inch silicon wafer at a rotation speed of 2000 rpm for 1 minute, and then baked at 80° C. for 1 minute, thereby forming a photoresist layer on the silicon wafer, i.e., the pre-coating layer.
[0091] A number of similar pre-coated layer samples were exposed to a 248 nm deep ultraviolet light source through a patterning mask at different exposure doses, and then the exposed pre-coated layer was developed with a developer. The developer used was decahydronaphthalene, and the exposure dose used was 45 mJ / cm2. 2 , 75mJ / cm 2 , 110mJ / cm 2 The obtained patterned photoresist layers are shown in Figures 11 to 13. The line widths of the linear patterns are 429.9 nm, 468.9 nm, and 513.6 nm, respectively. As the exposure dose increases, the line widths of the linear patterns formed using the same mask increase to some extent, but overall they are all around 0.4 to 0.5 micrometers.
[0092] Several similar pre-deposition layer samples were exposed under the same electron beam source through different patterning masks. The exposure dose was 50 μC, and then the exposed pre-deposition layer was developed using decahydronaphthalene as a developer. The resulting patterned photoresist layers are shown in Figures 14 to 16. The line widths of the linear patterns are 100 nm, 40 nm, and 25 nm, respectively, and are dense lines with a ratio of (L / S) = 1:1 to the blank.
[0093] Similar pre-deposited layer samples were exposed to similar extreme UV exposure conditions through different patterning masks, all at a dose of 7 mJ / cm. 2The exposed pre-deposited layer was then developed using decahydronaphthalene as a developer. The resulting patterned photoresist layer is shown in Figure 17. The period of the patterns (i.e., the sum of the widths of one line and one blank bar) are 100 nm (P100), 70 nm (P70), 50 nm (P50), and 44 nm (P44), respectively.
[0094] The pre-deposited layer samples were exposed to 300 mJ / cm through different patterning masks. 2 The pre-deposition layer was exposed to light with a 254 nm ultraviolet light source, and then developed using tetrahydronaphthalene as a developer. The resulting patterned photoresist layer is shown in Figures 18-19. The line width of the linear pattern in Figure 19 is 8.87 μm. The exposure was performed under air test conditions, and the exposure dose was high because oxygen has an inhibitory effect on the reaction.
[0095] As can be seen from the above, photolithographic images can be formed under exposure to ultraviolet light, deep ultraviolet light, extreme ultraviolet light, and electron beams without the need for an initiator or catalyst.
[0096] Comparative Example 1 1) 1.22 g (5 mmol) of benzoic acid and 1.92 g (20.4 mmol) of N-vinylimidazole were placed in a flask and mixed. At the same time, 15 mL of ethyl acetate was added and the mixture was dissolved by mixing for 2 minutes.
[0097] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0098] 3) After the reaction was completed, the mixture was rotary evaporated at 30° C. for 20 minutes under a pressure of 30 mbar.
[0099] Since the content of benzoic acid in Comparative Example 1 was too low, a white precipitate was formed in the solution after the reaction in step 2), and the photoresist particles could not be obtained.
[0100] Comparative Example 2 1) 48.8 g (200 mmol) of benzoic acid and 1.92 g (20.4 mmol) of N-vinylimidazole were placed in a flask and mixed. At the same time, 15 mL of ethyl acetate was added and the mixture was dissolved by mixing for 2 minutes.
[0101] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0102] 3) After the reaction was completed, the mixture was rotary evaporated at 30° C. for 20 minutes under a pressure of 30 mbar.
[0103] Since the content of benzoic acid in Comparative Example 2 was too high, a white precipitate was formed in the solution after the reaction in step 2), and the photoresist particles could not be obtained.
[0104] Comparative Example 3 1) 4.88 g (20 mmol) of benzoic acid and 0.48 g (5.1 mmol) of N-vinylimidazole were placed in a flask and mixed. At the same time, 15 mL of ethyl acetate was added and the mixture was mixed for 2 minutes to dissolve.
[0105] 2) 4.38 g (20 mmol) of zinc acetate dihydrate was placed in a flask, 30 mL of ethyl acetate was added, and the mixed solution obtained in 1) was added dropwise to the flask and stirred at 65° C. for 24 hours.
[0106] 3) After the reaction was completed, the mixture was rotary evaporated at 30° C. for 20 minutes under a pressure of 30 mbar.
[0107] Since the content of N-vinylimidazole in Comparative Example 3 was too low, white precipitate was formed in the solution after the reaction in step 2), and the photoresist particles could not be obtained.
[0108] The technical features of the above embodiments may be combined in any combination, and for the sake of brevity, not all possible combinations of the technical features of the above embodiments are described, but any combination of these technical features should be considered to be within the scope described herein, unless they are inconsistent.
[0109] The above embodiments merely represent some embodiments of the present application, and the description is more specific and detailed, but should not be understood as limiting the scope of the patent application. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of the present application, all of which are within the scope of protection of the present application. Therefore, the scope of protection of the present application should be in accordance with the appended claims.
Claims
1. 1. Zinc-based organometallic nanoparticles, The zinc-based organometallic nanoparticles have a core-shell structure, and the general formula of the zinc-based organometallic nanoparticles is Zn x O y [A] 2x [B] 2 (wherein x is 2 or 3, 2x≦y≦4x, and Zn x O y is a core of the core-shell structure, A is a first organic ligand, and B is a second organic ligand, the first organic ligand A and the second organic ligand B jointly constitute a shell of the core-shell structure, the first organic ligand A is benzoic acid, and the second organic ligand B is N-vinylimidazole or N-methylimidazole.
2. x=3, and two Zn atoms are x O y 2. The zinc-based organometallic nanoparticle according to claim 1, characterized in that the second organic ligands B are located at opposite ends of the core and bond to N atoms in the two second organic ligands B, respectively.
3. x=2, two Zn atoms are bonded to the first organic ligand A through the surrounding O atoms, and two N atoms in the second organic ligand B are bonded to the Zn x O y 2. The zinc-based organometallic nanoparticle according to claim 1, characterized in that the two Zn atoms are bonded to the two ends of the core, respectively.
4. The general formula of the zinc-based organometallic nanoparticles is Zn 2 O 8 [A] 4 [B] 2 , Zn 3 O 12 [A] 6 [B] 2 or Zn 3 O 10 [A] 6 [B] 2 2. The zinc-based organometallic nanoparticle according to claim 1,
5. 5. The zinc-based organometallic nanoparticles according to claim 1, characterized in that the size of the zinc-based organometallic nanoparticles is 1 nm to 3 nm.
6. A method for producing zinc-based organometallic nanoparticles according to any one of claims 1 to 5, comprising the steps of: mixing a zinc metal salt with an organic solvent to obtain a zinc metal salt solution; mixing the zinc metal salt solution with a first organic ligand source and a second organic ligand source, and reacting the mixture with heating and stirring; The method for producing zinc-based organometallic nanoparticles according to any one of claims 1 to 5, further comprising the step of subjecting the reaction product to vacuum rotary evaporation to remove the organic solvent.
7. The method for producing zinc-based organometallic nanoparticles according to claim 6, characterized in that the molar ratio of the zinc metal salt, the first organic ligand source, and the second organic ligand source is 1:(0.5-6):(0.5-6).
8. The heating and stirring temperature is 50 to 120° C., and the heating and stirring time is 10 to 40 hours. The temperature of the vacuum rotary evaporation is 20 to 80° C.
7. The method for producing zinc-based organometallic nanoparticles according to claim 6, wherein the pressure of the vacuum rotary evaporation is 5 to 40 mbar.
9. The heating and stirring temperature is 50 to 80°C and the time is 15 to 28 hours, 9. The method for producing zinc-based organometallic nanoparticles according to claim 8, wherein the temperature of the vacuum rotary evaporation is 20 to 40°C.
10. A zinc-based organometallic nanoparticle crystal, A zinc-based organometallic nanoparticle crystal, which is obtained by redissolving the product of the vacuum rotary evaporation in an organic solvent and then crystallizing the product, as described in any one of claims 1 to 5 or the zinc-based organometallic nanoparticle manufacturing method described in any one of claims 6 to 9.
11. A photoresist comprising: A photoresist obtained by dispersing one or two of the zinc-based organometallic nanoparticles according to any one of claims 1 to 5 and the zinc-based organometallic nanoparticle crystals according to claim 10 in an organic dispersion solvent.
12. 12. The photoresist of claim 11, wherein the organic dispersion solvent is any one or more selected from the group consisting of ethyl acetate, butyl acetate, propylene glycol monoethyl ether acetate, propylene glycol methyl ether acetate, 1-ethoxy-2-propanol, methyl alcohol, ethyl alcohol, and propyl alcohol.
Citation Information
Patent Citations
Zinc oxide nanocrystal and nanocomposite
JP2009046356A
Metal oxide nanoparticle and photoresist composition
JP2015157807A
Photosensitive composition and pattern formation method
JP2017173537A
Organically modified metal oxide nanoparticles, production method thereof, EUV photoresist material and production method for etching mask
WO2020004172A1
